TMPRSS2 and COVID-19: Therefore, camostat mesylate, which has a favorable safety profile (20), might be suitable for prevention and treatment of COVID-19 and related viral diseases, because SARS-CoV, MERS-CoV and several influenza A viruses depend on TMPRSS2 for spread and pathogenesis (14).